Adaptimmune Therapeutics Plc of the UK has raised $191.3 million in an initial public offering of its shares on Nasdaq. The offer of 11.25 million American Depositary Shares (ADSs) was priced at $17 per share. Approximately 1.7 million shares have also been set aside for overallotments.
